AG008MEO

81409-90-7 | Cabergoline

Chemical structure of Cabergoline, CAS 81409-90-7
AG008MEO
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 81409-90-7
Catalog Number AG008MEO(AGN-PC-0UJDZ1)
Chemical Name Cabergoline
IUPAC Name (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
InChI InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
InChI Key KORNTPPJEAJQIU-KJXAQDMKSA-N
MDL Number MFCD00867887
Molecular Formula C26H37N5O2
Molecular Weight 451.6043
SMILES C=CCN1C[C@H](C(N(C(NCC)=O)CCCN(C)C)=O)C[C@@]2([H])[C@@]1([H])CC3=CNC4=C3C2=CC=C4
UNII LL60K9J05T
Synonyms
1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate, Cabaser, Cabaseril, cabergoline, cabergoline diphosphate, Dostinex, FCE 21336, FCE-21336, Galastop, cabergoline, Dostinex, 81409-90-7, Cabaser, Cabergolina, Cabergolinum, Cabaseril, Cabergolinum [Latin], Cabergolina [Spanish], FCE-21336, UNII-LL60K9J05T, C26H37N5O2, FCE 21336, BRN 6020775, 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, CHEBI:3286, LL60K9J05T, Galastop, MFCD00867887, DSSTox_CID_2719, DSSTox_RID_76698, DSSTox_GSID_22719, Sogilen, Dostinex (TN), Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-, Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, Cabaser (TN), CAS-81409-90-7, Cabergoline [USAN:BAN:INN], SR-05000001493, Caberlin, Cabergoline (JAN/USAN/INN), NCGC00167821-01, Cabergoline [USAN:USP:INN:BAN], CG-101, GTPL37, AC1L1HO0, AC1Q5OQ0, 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate, SCHEMBL42292, BIDD:GT0775, CHEMBL1201087, DTXSID6022719, Cabergoline, >=98% (HPLC), CTK8F8406, KORNTPPJEAJQIU-KJXAQDMKSA-N, HMS2090A09, ZINC3800008, Tox21_112589, BDBM50426497, 1-Ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'beta-carbonyl)urea, 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea, AKOS015961587, Tox21_112589_1, DB00248, (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea, NCGC00344544-01, (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide, AC-26126, AN-36255, BC207368, K450, LS-64370, SC-19831, FT-0081285, FT-0650562, C08187, D00987, AB01275484-01, 409C907, SR-05000001493-1, SR-05000001493-2, BRD-K86882815-001-01-6, Cabergoline, European Pharmacopoeia (EP) Reference Standard, Cabergoline, United States Pharmacopeia (USP) Reference Standard, 1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)-propyl]-3-ethylurea, 6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide, N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide, (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, (9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, 1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carbonyl]urea, 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea, 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea, Neutral Violet Bl, Cabergoline diphosphate, D04EGX, Cabergoline [USAN:INN:BAN], CID54746, C26-H37-N5-O2, CS-O-06311, B3541, A13844, C047047, D000077465, (8-beta)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)ergoline-8-carboxamide, Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited